Florida Pancreas Collaborative

July 16, 2019

The Florida Pancreas Collaborative Next-Generation Biobank: Reducing Health Disparities and Improving Survival for Pancreatic Cancer

  • Clinical Trial Information

    Trial Contact: De Leon, Ma Theresa; Jarquin-Castillo, Katherine

    Trial Phone: 321.841.8284 ; 321.841.1077

  • IRB No: S19.018.02

    Protocol Abbrev: Florida Pancreas

    Principal Investigator: Debashish Bose, MD

    Age Group: Adult

    Secondary Protocol No: Florida Pancreas Study

    ClinicalTrials.gov ID: NCT03851133

  • Objective

    The overarching goal of our collaborative is to create a state-wide biobank to conduct basic, clinical, population-based, and translational PC health disparities research. Our secondary goal will be to utilize the biobank to test the central hypothesis that cancer cachexia may underlie racial disparities in PC.

  • Key Eligibility

    Patient is 18 years or older.
    •   Patient presents for evaluation at a participating FPC site with a strong clinical suspicion or diagnosis of pancreatic cancer based on symptoms, imaging, biopsy, and/or blood-work.
    •   Self-reports as NHW, AA, or Hispanic.
    •   Able to understand and voluntarily sign the informed consent.
    •   Willing to complete study questionnaire(s) and donate medical images and biological specimens (including tissue and blood) obtained at the time of standard of care procedures (biopsy, surgery, and/or venipuncture) after signing the informed consent document.